Table 3. Biochemical Values of HTN-1 Patients.
| Chlortalidone/amiloride | Losartan | |
|---|---|---|
| Glycemia (mg/dL) | 132.9 ± 93.85 | 97.0 ± 33.8* |
| Glycated hemoglobin (mg/dL) | 7.02 ± 2.37 | 5.7 ± 1.0* |
| Total cholesterol (mg/dL) | 206.9 ± 44.61 | 217.1 ± 33.6 |
| LDL-cholesterol (mg/dL) | 119.7 ± 34.92 | 127.0 ± 34.5 |
| HDL-cholesterol (mg/dL) | 51.47 ± 15.37 | 49.6 ± 14.0 |
| Triglycerides (mg/dL) | 178.0 ± 88.69 | 201.6 ± 93.5* |
| Creatinine (mg/dL) | 0.95 ± 0.22 | 1.12 ± 0.9 |
| eGFR (MDRD) | 81.67 ± 16.69 | 78.3 ± 28.1 |
| Microalbuminuria (mg/24 h) | 14.67 ± 11.60 | 10.4 ± 8.6 |
| Potassium (mEq/L) | 4.04 ± 0.49 | 4.3 ± 0.29 |
| Uric acid (mg/dL) | 6.08 ± 2.14 | 5.9 ± 1.3 |
| N | 25 | 25 |
Values are expressed as mean ± SD. *P < 0.05. Chlortalidone 25 mg/amiloride 5 mg (q.d.). Losartan 50 mg (b.i.d.). HTN-1: stage 1 hypertension; LDL-c: low-density lipoprotein fraction; HDLc: high-density lipoprotein fraction; GFR-e: estimated glomerular filtration rate.